Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IMATINIB Cause Wrong technique in product usage process? 119 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Wrong technique in product usage process have been filed in association with IMATINIB (Imatinib). This represents 0.3% of all adverse event reports for IMATINIB.

119
Reports of Wrong technique in product usage process with IMATINIB
0.3%
of all IMATINIB reports
1
Deaths
15
Hospitalizations

How Dangerous Is Wrong technique in product usage process From IMATINIB?

Of the 119 reports, 1 (0.8%) resulted in death, 15 (12.6%) required hospitalization, and 2 (1.7%) were considered life-threatening.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 119 reports have been filed with the FAERS database.

What Other Side Effects Does IMATINIB Cause?

Death (9,708) Drug ineffective (2,628) Nausea (2,379) Diarrhoea (2,203) Fatigue (1,810) Malignant neoplasm progression (1,716) Vomiting (1,599) Malaise (1,361) Drug intolerance (1,354) Drug resistance (1,293)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which IMATINIB Alternatives Have Lower Wrong technique in product usage process Risk?

IMATINIB vs IMBRUVICA IMATINIB vs IMDEVIMAB IMATINIB vs IMEGLIMIN IMATINIB vs IMETELSTAT IMATINIB vs IMIDAPRIL

Related Pages

IMATINIB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process IMATINIB Demographics